PROTEONOMY
Live / Applied — Third extension granted (statement of use) (as of 24 Oct 2025)
What this means for you
Not registered yet, but its 10 Aug 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98126422
- Mark type
- Stylized text
- Filed
- 10 Aug 2023
- Published for opposition
- 20 Aug 2024
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 010 — Medical apparatus: Medical diagnostic apparatus for testing and sequencing DNA and RNA and proteins for genomic, transcriptomic, and proteomic analysis
- Class 042 — Scientific and technological services: Software as a service (SaaS) services featuring software for life science analytics; research services in the fields of genomic, transcriptomic, and proteomic analysis; genomic and proteomic analysis and sequencing services for scientific, medical, and research purposes; medical and scientific research in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; DNA analysis and sequencing services for scientific, medical, and research purposes; research, development and consultancy in the field of genomics and proteomics; medical research, namely, compiling data for research purposes in the field of genomics and proteomics; providing on-line non-downloadable software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; platform as a service (PaaS) featuring computer software platforms for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; software as a service (SaaS) services featuring software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics
Owner
- ProFound Therapeutics, Inc., Cambridge, MA, US
- ProFound Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 27 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Oct 2025 — SOU EXTENSION 3 GRANTED
- 24 Oct 2025 — SOU EXTENSION 3 FILED
- 24 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 11 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Oct 2025 — SOU EXTENSION 2 GRANTED
- 10 Oct 2025 — SOU EXTENSION 2 FILED
- 10 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 11 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Apr 2025 — SOU EXTENSION 1 GRANTED
- 10 Apr 2025 — SOU EXTENSION 1 FILED
- 10 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 20 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 Aug 2024 — PUBLISHED FOR OPPOSITION